INS and diabetes mellitus: Moreover, the leptin-induced overexpression of IGFBP-2 has been shown to reverse diabetes in insulin-resistant obese mice and hyperinsulinemic clamp studies showed a threefold improvement in hepatic insulin sensitivity following IGFBP-2 treatment of ob/ob mice [23].